Sun, Dr. Reddy’s rework strategies to deal with US market; Novartis sells troubled US biz to Aurobindo
This week, Phispers has news on Indian generic drug makers. First, Sun Pharma and Dr. Reddy’s Laboratories announced thei...
Impressions : 2942
High-level exit at Dr. Reddy’s; Drug stockpiling starts as firms face ‘no-deal Brexit’ blues
With Britain preparing for a ‘no-deal Brexit’, Phispers this week looks at how pharmaceutical companies are ex...
Impressions : 3396
Pfizer rejigs into three businesses; Cancer causing impurity in China-made API leads to major EU drug recall
This week in Phispers, we bring you news on Pfizer reorganizing itself into three businesses — Innovative Medicines, Esta...
Impressions : 4814
China sees sharp rise in U.S. generic approvals; GSK opts out of Pfizer’s OTC business race
This week,
Phispers brings you news on Pfizer’s OTC auction. After Reckitt Benckiser, even GSK opted out of the race, le...
Impressions : 3737
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.